At the time of writing, Biolife Solutions Inc [BLFS] stock is trading at $25.01, up 11.45%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The BLFS shares have gain 3.73% over the last week, with a monthly amount glided 10.61%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Biolife Solutions Inc [NASDAQ: BLFS] stock has seen the most recent analyst activity on September 30, 2024, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $29. Previously, Jefferies started tracking the stock with Buy rating on April 04, 2024, and set its price target to $22. On July 11, 2023, Craig Hallum initiated with a Buy rating and assigned a price target of $29 on the stock. Oppenheimer upgraded its rating to a Outperform but stick to its price target of $28 on April 25, 2022. B. Riley Securities initiated its recommendation with a Buy and recommended $61 as its price target on October 19, 2021. In a note dated May 14, 2021, The Benchmark Company downgraded an Hold rating on this stock.
For the past year, the stock price of Biolife Solutions Inc fluctuated between $11.91 and $28.88. Currently, Wall Street analysts expect the stock to reach $27.33 within the next 12 months. Biolife Solutions Inc [NASDAQ: BLFS] shares were valued at $25.01 at the most recent close of the market. An investor can expect a potential return of 9.28% based on the average BLFS price forecast.
Analyzing the BLFS fundamentals
According to Biolife Solutions Inc [NASDAQ:BLFS], the company’s sales were 123.36M for trailing twelve months, which represents an -8.27% plunge. Gross Profit Margin for this corporation currently stands at 0.46% with Operating Profit Margin at -0.23%, Pretax Profit Margin comes in at -0.26%, and Net Profit Margin reading is -0.37%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.14 and Total Capital is -0.08. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 22.90 points at the first support level, and at 20.80 for the second support level. However, for the 1st resistance point, the stock is sitting at 26.11, and for the 2nd resistance point, it is at 27.22.
Ratios To Look Out For
It is important to note that Biolife Solutions Inc [NASDAQ:BLFS] has a current ratio of 2.78. Further, the Quick Ratio stands at 1.78, while the Cash Ratio is 0.75. Considering the valuation of this stock, the price to sales ratio is 9.40, the price to book ratio is 3.55.
Transactions by insiders
Recent insider trading involved Mathew Aby J., EVP & Chief Scientific Officer, that happened on Nov 15 ’24 when 25000.0 shares were sold. EVP & Chief Scientific Officer, Mathew Aby J. completed a deal on Nov 18 ’24 to sell 17604.0 shares. Meanwhile, Chief Marketing Officer Berard Todd sold 91.0 shares on Nov 12 ’24.
